MPM BioVentures 2014, L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 86,220 shares at $27.13 ($2.3M) on 2021-10-13, disclosed to the SEC on 2021-10-14.
Scheduled sale ($2.3M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.09 | 8,521 | $231K | 9.9% |
| 2 | $27.09 | 8,521 | $231K | 9.9% |
| 3 | $27.13 | 20,929 | $568K | 24.2% |
| 4 | $27.13 | 20,929 | $568K | 24.2% |
| 5 | $27.30 | 27,320 | $746K | 31.8% |
| Total | $27.18 avg | 86,220 |
| $2.3M |
| 100% |
| Filing → |
| TRDA | SELL | 2026-08-31 | $616K | — | Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| HOWL | SELL | 2025-11-12 | $438K | — | Filing → |